Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease

Amino Acids

Volumn 47, Issue 3, 2015, Pages 603-615

  Lake, April D ^a   Novak, Petr ^b   Shipkova, Petia ^c   Aranibar, Nelly ^c   Robertson, Donald G ^c   Reily, Michael D ^c   Lehman Mckeeman, Lois D ^c   Vaillancourt, Richard R ^a   Cherrington, Nathan J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b INSTITUTE OF PLANT MOLECULAR BIOLOGY   (Czech Republic)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

Branched chain amino acids; Metabolomics; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Transcriptomics

Indexed keywords

ACETYLCARNITINE; ALANINE; BRANCHED CHAIN AMINO ACID; BUTYRYLCARNITINE; CARNITINE; HEXANOYLCARNITINE; ISOBUTYRYLCARNITINE; ISOLEUCINE; ISOVALERYLCARNITINE; LAURYLCARNITINE; LEUCINE; LINOLEOYLCARNITINE; OLEOYLCARNITINE; PALMITOYLCARNITINE; PHENYLALANINE; PROPIONYLCARNITINE; STEAROYLCARNITINE; TYROSINE; UNCLASSIFIED DRUG; VALINE;

ALCOHOLIC FATTY LIVER; AMINO ACID METABOLISM; ARTICLE; BCAA GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; GENE; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; METABOLOMICS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; STEATOSIS; TRANSCRIPTOMICS; FEMALE; GENE EXPRESSION PROFILING; GENETICS; MALE; METABOLISM; SIGNAL TRANSDUCTION;

CARNITINE; FEMALE; GENE EXPRESSION PROFILING; HUMANS; ISOLEUCINE; LEUCINE; MALE; METABOLOMICS; NON-ALCOHOLIC FATTY LIVER DISEASE; SIGNAL TRANSDUCTION; VALINE;

EID: 84925508423     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-014-1894-9     Document Type: Article

References (44)

1. Adams SH (2011) Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv Nutr Int Rev J 2(6):445-456
2. Adeva MM, Calvino J, Souto G, Donapetry C (2012) Insulin resistance and the metabolism of branched-chain amino acids in humans. Amino Acids 43(1):171-181
3. Ali R, Cusi K (2009) New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD). Ann Med 41(4):265-278
4. Bellentani S, Scaglioni F, Marino M, Bedogni G (2010) Epidemiology of non-alcoholic fatty liver disease. Dig Dis 28(1):155-161
5. Bodoy S, Fotiadis D, Stoeger C, Kanai Y, Palacin M (2012) The small SLC43 family: facilitator system L amino acid transporters and the orphan EEG1. Mol Aspects Med 12:S0098-S2997
6. Bonora E (2006) The metabolic syndrome and cardiovascular disease. Ann Med 38:64-80
7. Boujedidi H, Bouchet-Delbos L, Cassard-Doulcier AM, Njike-Nakseu M, Maitre S, Prevot S, Dagher I, Agostini H, Voican CS, Emilie D, Perlemuter G, Naveau S (2012) Housekeeping gene variability in the liver of alcoholic patients. Alcohol Clin Exp Res 36(2):258-266
8. Congiu M, Slavin JL, Desmond PV (2011) Expression of common housekeeping genes is affected by disease in human hepatitis C virus-infected liver. Liver Int 31(3):386-390
9. Dam-Larsen S (2004) Long-term prognosis of fatty liver: risk of chronic liver disease and death. Gut 53:750-755
10. Day CP (2002) Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 16(5):663-678
11. Day CP, James OFW (1998) Steatohepatitis: a tale of two ''hits''? Gastroenterology 114(4):842-845
12. Dodd KM, Tee AR (2012) Leucine and mTORC1: a complex relationship. Am J Physiol Endocrinol Metabol 302(11):E1329-E1342
13. Fabbrini E, Sullivan S, Klein S (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51:679-689
14. Fisher CD, Lickteig AJ, Augustine LM, Ranger-Moore J, Jackson JP, Ferguson SS, Cherrington NJ (2009) Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease. Drug Metab Dispos 37(10):2087-2094
15. Fukuhara D, Kanai Y, Chairoungdua A, Babu E, Bessho F, Kawano T, Akimoto Y, Endou H, Yan K (2007) Protein characterization of Na+-independent system L amino acid transporter 3 in mice - a potential role in supply of branched-chain amino acids under nutrient starvation. Am J Pathol 170(3):888-898
16. Greco D, Kotronen A, Westerbacka J, Puig O, Arkkila P, Kiviluoto T, Laitinen S, Kolak M, Fisher RM, Hamsten A, Auvinen P, Yki-Jarvinen H (2008) Gene expression in human NAFLD. Am J Physiol Gastrointest Liver Physiol 294(5):G1281-G1287
17. Hagiwara A, Nishiyama M, Ishizaki S (2012) Branched-chain amino acids prevent insulin-induced hepatic tumor cell proliferation by inducing apoptosis through mTORC1 and mTORC2-dependent mechanisms. J Cell Physiol 227(5):2097-2105
18. Hardwick RN, Fisher CD, Canet MJ, Scheffer GL, Cherrington NJ (2011) Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease. Drug Metab Dispos 39(12):2395-2402
19. Hardwick RN, Ferreira DW, More VR, Lake AD, Lu Z, Manautou JE, Slitt AL, Cherrington N (2012) Altered UDP-glucuronosyltransferase (UGT) and sulfotransferase (SULT) expression and function during progressive stages of human nonalcoholic fatty liver disease. Drug Metab Dispos 41(3):554-661
20. Hayaishi S, Chung H, Kudo M, Ishikawa E, Takita M, Ueda T, Kitai S, Inoue T, Yada N, Hagiwara S, Minami Y, Ueshima K (2011) Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis. Dig Dis 29(3):326-332
21. Hnatyshyn S, Shipkova P, Sanders M (2013) Expedient data mining for nontargeted high-resolution LC-MS profiles of biological samples. Bioanalysis 5(10):1195-1210
22. Kalhan SC, Guo L, Edmison J, Dasarathy S, McCullough AJ, Hanson RW, Milburn M (2011) Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism 60(3):404-413
23. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6):1313-1321
24. Koehler EM, Schouten JNL, Hansen BE, van Rooij FJA, Hofman A, Stricker BH, Janssen HLA (2012) Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. J Hepatol 57(6):1305-1311
25. Lake AD, Novak P, Fisher CD, Jackson JP, Hardwick RN, Billheimer DD, Klimecki WT, Cherrington NJ (2011) Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease. Drug Metab Dispos 39(10):1954-1960
26. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N (2001) Nonalcoholic fatty liver disease - a feature of the metabolic syndrome. Diabetes 50(8):1844-1850
27. Mariotta L, Ramadan T, Singer D, Guetg A, Herzog B, Stoeger C, Palacin M, Lahoutte T, Camargo SMR, Verrey F (2012) T-type amino acid transporter TAT1 (Slc16a10) is essential for extracellular aromatic amino acid homeostasis control. J Physiol 590(24):6413-6424
28. McCullough AJ (2006) Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 40:S17-S29
29. McCullough AJ (2011) Epidemiology of the metabolic syndrome in the USA. J Dig Dis 12(5):333-340
30. Merrell MD, Cherrington NJ (2011) Drug metabolism alterations in nonalcoholic fatty liver disease. Drug Metab Rev 43(3):317-334
31. Miyake T, Abe M, Furukawa S, Tokumoto Y, Toshimitsu K, Ueda T, Yamamoto S, Hirooka M, Kumagi T, Hiasa Y, Matsuura B, Onji M (2012) Long-term branched-chain amino acid supplementation improves glucose tolerance in patients with nonalcoholic steatohepatitis-related cirrhosis. Intern Med 51(16):2151-2155
32. Nagao Y, Kawaguchi T, Ide T, Sata M (2012) Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study. Virol J 9(1):282
33. Newgard C (2012) Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab 15(5):606-614
34. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, Rochon J, Gallup D, Ilkayeva O, Wenner BR, Yancy J, Eisenson H, Musante G, Surwit RS, Millington DS, Butler MD, Svetkey LP (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9(4):311-326
35. Rubinstein E, Lavine JE, Schwimmer JB (2008) Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. Semin Liver Dis 28(4):380-385
36. Schooneman MG, Vaz FM, Houten SM, Soeters MR (2013) Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes 62(1):1-8
37. She P, Van Horn C, Reid T, Hutson SM, Cooney RN, Lynch CJ (2007) Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metabol 293(6):E1552-E1563
38. She P, Olson KC, Kadota Y, Inukai A, Shimomura Y (2013) Leucine and protein metabolism in obese Zucker rats. PLoS One 8(3):e59443
39. Suryawan A, Hawes JW, Harris RA, Shimomura Y, Jenkins AE, Hutson SM (1998) A molecular model of human branched-chain amino acid metabolism. Am J Clin Nutr 68(1):72-81
40. Sweatt AJ, Wood M, Suryawan A, Wallin R, Willingham MC, Hutson SM (2004) Branched-chain amino acid catabolism: unique segregation of pathway enzymes in organ systems and peripheral nerves. Am J Physiol Endocrinol Metabol 286(1):E64-E76
41. Tajiri K, Shimizu Y (2013) Branched-chain amino acids in liver diseases. World J Gastroenterol 19(43):7620-7629
42. Takanaga H, Mackenzie B, Peng JB, Hediger MA (2005) Characterization of a branched-chain amino-acid transporter SBAT1 (SLC6A15) that is expressed in human brain. Biochem Biophys Res Commun 337(3):892-900
43. Wong VWS, Chu WCW, Wong GLH, Chan RSM, Chim AML, Ong A, Yeung DKW, Yiu KKL, Chu SHT, Woo J, Chan FKL, Chan HLY (2012) Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 61(3):409-415
44. Yoshida R, Yagi T, Sadamori H, Matsuda H, Shinoura S, Umeda Y, Sato D, Utsumi M, Nagasaka T, Okazaki N, Date A, Noguchi A, Tanaka A, Hasegawa Y, Sakamoto Y, Fujiwara T (2012) Branched-chain amino acid-enriched nutrients improve nutritional and metabolic abnormalities in the early post-transplant period after living donor liver transplantation. J Hepato Biliary Pancreat Sci 19(4):438-448